| Phase 4 |
| NCT06624696 |
Inhaling Penehyclidine to Prevent Perioperative Respiratory Adverse Events in Children at… |
Respiratory Hypersensitivity |
Recruiting |
| NCT06437288 |
Hematoporphyrin Photodynamic Therapy for Esophageal Cancer |
Esophageal Cancer |
Enrolling by Invitation |
| Phase 3 |
| NCT06726421 |
Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney… |
Renal Cell Carcinoma (Kidney Cancer) |
Recruiting |
| NCT06239727 |
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment… |
Nasopharyngeal Carcinoma |
Recruiting |
| NCT07125755 |
Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant… |
Squamous Cell Cancer of Head and Neck (SCCHN) |
Recruiting |
| NCT06545747 |
Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic… |
Non-small Cell Lung Cancer |
Recruiting |
| NCT07201337 |
Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in… |
Nasopharyngeal Cancinoma (NPC) |
Recruiting |
| NCT07481786 |
Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With… |
Lung Adenocarcinoma |
Recruiting |
| NCT07177794 |
Consolidation of Toripalimab and Capecitabine After Chemoradiotherapy in ESCC |
Esophageal Cancer |
Recruiting |
| NCT04944914 |
Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For… |
Nasopharyngeal Carcinoma |
Recruiting |
| NCT05357846 |
PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally… |
Squamous Cell Esophageal Carcinoma |
Recruiting |
| NCT07528209 |
Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally… |
Rectal Cancer |
Recruiting |
| NCT03907826 |
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma… |
Recurrent Nasopharyngeal Carcinoma |
Recruiting |
| NCT07311772 |
Prevention and Treatment of Radiation-Induced Oral Mucositis in NPC With Houyanqing Oral… |
Nasopharyngeal Cancinoma (NPC) |
Recruiting |
| NCT04436965 |
Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in… |
Nasopharyngeal Carcinoma |
Recruiting |
| NCT05340491 |
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised… |
Nasopharyngeal Carcinoma |
Recruiting |
| NCT05941741 |
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC |
Nasopharyngeal Carcinoma |
Recruiting |
| NCT03303495 |
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC |
Colorectal Neoplasms |
Recruiting |
| NCT05198609 |
Camrelizumab, Apatinib Plus HAIC Versus Camrelizumab and Apatinib for HCC With Portal… |
Hepatocellular Carcinoma |
Active, Not Recruiting |
| NCT07371897 |
Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial |
Head and Neck Squamous Cell Carcinoma HNSCC |
Not Yet Recruiting |
| NCT07373990 |
Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma |
Nasopharyngeal Cancinoma (NPC) |
Not Yet Recruiting |
| NCT07381660 |
SBRT Versus Surgical Resection for Small HCC |
Hepatocellular Carcinoma (HCC) |
Not Yet Recruiting |
| NCT07385079 |
Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma |
Nasopharyngeal Cancinoma (NPC) |
Not Yet Recruiting |
| NCT07402538 |
Surgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in… |
Oral Cancer |
Not Yet Recruiting |
| NCT07524413 |
Becotatug Vedotin (MRG003) With PD-1 Blockade and Chemoradiotherapy in High-Risk… |
Nasopharyngeal Cancinoma (NPC) |
Not Yet Recruiting |